0

Coronary Heart Disease Collection
 1-20 of 792 Articles
Web Exclusives |  16 August 2016 FREE
The Consult Guys - Fact or Fiction: O2 for Myocardial Infarction?Fact or Fiction: O2 for Myocardial Infarction?
Geno J. Merli, MD; Howard H. Weitz, MD
Ann Intern Med. 2016;165(4):CG1. doi:10.7326/W16-0008
Original Research |  19 July 2016
Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery DiseaseEconomic Outcomes With Anatomical vs. Functional Diagnostic Testing for CAD
Daniel B. Mark, MD, MPH; Jerome J. Federspiel, MD; Patricia A. Cowper, PhD; et al.
Ann Intern Med. 2016;165(2):94-102. doi:10.7326/M15-2639
Editorials |  19 July 2016
Measuring Diagnostic Health Care Costs in Stable Coronary Artery Disease: Should We Follow the Money?Measuring Diagnostic Health Care Costs in Stable CAD
Joe X. Xie, MD; Leslee J. Shaw, PhD
Ann Intern Med. 2016;165(2):147-148. doi:10.7326/M16-1048
Editorials |  5 July 2016
The Role of Randomized and Nonrandomized Studies in Evaluating Diagnostic StrategiesEvaluating Diagnostic Strategies
M.G. Myriam Hunink, MD, PhD; Kirsten E. Fleischmann, MD, MPH
Ann Intern Med. 2016;165(1):61-62. doi:10.7326/M16-0811
Editorials |  7 June 2016
Bioresorbable Vascular Scaffolds in Coronary Artery Disease: Weighing the Evidence and Next StepsBioresorbable Vascular Scaffolds
Seth S. Martin, MD, MHS; Rani K. Hasan, MD, MHS
Ann Intern Med. 2016;164(11):775-776. doi:10.7326/M16-0754
Reviews |  7 June 2016
Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-analysisEverolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents
Xin-Lin Zhang, MD; Li Zhu, MD; Zhong-Hai Wei, MD; et al.
Ann Intern Med. 2016;164(11):752-763. doi:10.7326/M16-0006
Editorials |  3 May 2016
Addressing Air Quality and Health as a Strategy to Combat Climate ChangeAddressing Air Quality and Health as a Strategy to Combat Climate Change
Elizabeth A. Joy, MD, MPH; Benjamin D. Horne, PhD, MPH; Steven Bergstrom, BS
Ann Intern Med. 2016;164(9):626-627. doi:10.7326/M16-0507
Reviews |  3 May 2016
Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome: A Narrative ReviewRole of PCSK9 Inhibition in ACS
Eliano P. Navarese, MD, PhD; Michalina Kołodziejczak, MD; Dean J. Kereiakes, MD; et al.
Ann Intern Med. 2016;164(9):600-607. doi:10.7326/M15-2994
Ideas and Opinions |  19 April 2016
U.S. Dietary Guidelines: An Evidence-Free ZoneU.S. Dietary Guidelines: An Evidence-Free Zone
Steven E. Nissen, MD
Ann Intern Med. 2016;164(8):558-559. doi:10.7326/M16-0035
Beyond the Guidelines |  5 April 2016
Should We Screen for Coronary Heart Disease in Asymptomatic Persons?: Grand Rounds Discussion From Beth Israel Deaconess Medical CenterScreening for Asymptomatic Heart Disease
Gerald W. Smetana, MD; Donald E. Cutlip, MD; Duane S. Pinto, MD, MPH
Ann Intern Med. 2016;164(7):479-487. doi:10.7326/M15-2910
Web Exclusives |  5 April 2016 FREE
Annals for Educators - 5 April 2016Annals for Educators - 5 April 2016
Darren B. Taichman, MD, PhD
Ann Intern Med. 2016;164(7):ED7. doi:10.7326/AFED201604050
Editorials |  15 December 2015
A Call to Arms: Radial Artery Access for Percutaneous Coronary InterventionA Call to Arms
Michael P. Savage, MD; David L. Fischman, MD; Nicholas J. Ruggiero, MD
Ann Intern Med. 2015;163(12):956-957. doi:10.7326/M15-2444
Reviews |  15 December 2015
Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysisRadial Access in Acute Coronary Syndromes
Giuseppe Andò, MD, PhD; Davide Capodanno, MD, PhD
Ann Intern Med. 2015;163(12):932-940. doi:10.7326/M15-1277
Editorials |  17 November 2015
Celebrating the ACP Centennial: From the Annals Archive—Acute Coronary SyndromesCelebrating the ACP Centennial
Deborah Cotton, MD, MPH
Ann Intern Med. 2015;163(10):798. doi:10.7326/M15-2093
Original Research |  17 November 2015
Effectiveness of an Early Versus a Conservative Invasive Treatment Strategy in Acute Coronary Syndromes: A Nationwide Cohort StudyEffectiveness of Early Invasive Treatment Strategies in ACS
Kim Wadt Hansen, MD; Rikke Sorensen, MD; Mette Madsen, MSc; et al.
Ann Intern Med. 2015;163(10):737-746. doi:10.7326/M15-0303
Ideas and Opinions |  20 October 2015
The ADAPTABLE Trial and PCORnet: Shining Light on a New Research ParadigmThe ADAPTABLE Trial and PCORnet
Adrian F. Hernandez, MD, MHS; Rachael L. Fleurence, PhD; Russell L. Rothman, MD, MPP
Ann Intern Med. 2015;163(8):635-636. doi:10.7326/M15-1460
Original Research |  1 September 2015
Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort StudyVisit-to-Visit Variability of BP on CVD and Mortality Outcomes
Paul Muntner, PhD; Jeff Whittle, MD; Amy I. Lynch, PhD; et al.
Ann Intern Med. 2015;163(5):329-338. doi:10.7326/M14-2803
Reviews |  21 July 2015 FREE
Intermediate- and Long-Term Cognitive Outcomes After Cardiovascular Procedures in Older Adults: A Systematic ReviewCognitive Outcomes After Cardiovascular Procedures in Older Adults
Howard A. Fink, MD, MPH; Laura S. Hemmy, PhD; Roderick MacDonald, MS; et al.
Ann Intern Med. 2015;163(2):107-117. doi:10.7326/M14-2793
Reviews |  21 July 2015
Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and Meta-analysisDuration of Dual-Antiplatelet Therapy After Drug-Eluting Stents
Frederick A. Spencer, MD; Manya Prasad, MBBS; Per O. Vandvik, MD, PhD; et al.
Ann Intern Med. 2015;163(2):118-126. doi:10.7326/M15-0083
Original Research |  7 July 2015
Long-Term Prognosis After Coronary Artery Calcification Testing in Asymptomatic Patients: A Cohort StudyLong-Term Prognosis After CAC Testing in Asymptomatic Patients
Leslee J. Shaw, PhD; Ashley E. Giambrone, PhD; Michael J. Blaha, MD; et al.
Ann Intern Med. 2015;163(1):14-21. doi:10.7326/M14-0612
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)